Serum Institute's multivalent meningococcal meningitis vaccine gets WHO prequalification

The Serum Institute of India (SII), world's largest vaccine maker by volumes on Wednesday said its vaccine to protect against the five predominant causes of meningococcal meningitis in Africa has been prequalified by the World Health Organisation (WHO), making the vaccine eligible to be procured by United Nations agencies and Gavi, the Vaccine Alliance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fJHg9Sk
via IFTTT